VA Study - Estrogen & Prostate Ca
RCT of 2313 patients recruited over 7 years
no change in eligibility criteria throughout
placebo patients in first 2.5 years had significantly worse survival than estrogen patients in the last 2.5 years
Previous slide
Next slide
Back to first slide
View graphic version